Researchers from the European Centre for Allergy Research Foundation (ECARF) and the Institute of Allergology at Charité Universitätsmedizin Berlin have conducted clinical trials on Respiray Wear A+, revealing that the wearable allergy relief device reduced the symptoms of pollen, dust mite and cat allergies more effectively than most anti-allergy medications or allergen-specific immunotherapy.
Full Article
WEDNESDAY, May 22, 2024 (HealthDay News) -- It might be hoped that replacing a diesel school bus with a clean electric model would pay off for health and the environment.
New research suggests that it does -- and gives a dollar figure for that payoff.